Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant
Categories
Health Care
Infographic: Key financials of Biogen (BIIB) Q2 2020 earnings report
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of 2020. Adjusted
Thermo Fisher Scientific (TMO) Earnings: 2Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) today announced its second quarter financial results for the period ended June 27, 2020. Net income
Infographic: Key highlights from Intuitive Surgical (ISRG) Q2 2020 earnings results
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported second quarter 2020 earnings results today. Revenues decreased 22% year-over-year to $852 million, due to lower
Abbott (ABT) could make a new 52-week high after upbeat Q2 results and rosier outlook
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday, shares of
AngioDynamics, Inc. (ANGO) Q4 2020 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Abbott Laboratories (ABT) Q2 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Johnson & Johnson (JNJ) Q2 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Chris DelOrefice -- Vice President, Investor Relations Paul Stoffels -- Vice
Johnson & Johnson (JNJ): Postponement of procedures hits medical devices unit hard in Q2
Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top and bottom
Infographic: Abbott (ABT) reports Q2 2020 earnings
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to
Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the
Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants: Lavina Talukdar -- Head
UnitedHealth Group Inc. (UNH) Q2 2020 Earnings Call Transcript
Unitedhealth Group Inc. (UNH) Q2 2020 earnings call dated July 15, 2020 Corporate Participants: David S. Wichmann -- Chief Executive Officer John Rex -- Executive Vice
Moderna medical chief: Varying infection rate to be the biggest challenge in Phase 3
A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its COVID-19 vaccine
Biocept (BIOC) – Is it worth buying?
Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we are seeing
Simulations Plus Inc (NASDAQ: SLP) Q3 2020 Earnings Call Transcript
Simulations Plus Inc (SLP) Q3 2020 earnings call dated July 09, 2020 Corporate Participants: Cameron Donahue -- Partner and Regional Vice President Shawn O'Connor -- Chief
Walgreens Boots Alliance Inc. (WBA) Q3 2020 Earnings Call Transcript
Walgreens Boots Alliance Inc. (WBA) Q3 2020 earnings call dated July 09, 2020 Corporate Participants: Gerald Gradwell -- Senior Vice President of Investor Relations
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2020 Earnings Call Transcript
Avid Bioservices, Inc. (CDMO) Q4 2020 earnings call dated June 30, 2020 Corporate Participants: Tim Brons -- Executive Vice President Rick Hancock -- Interim President and
Rite Aid (RAD) Q1 2021 earnings results: Is this a permanent turnaround?
It's been a disappointing first half for drugstore chain operators. However, after reporting better-than-expected top and bottom line figures for its first
Centogene N.V. (NASDAQ: CNTG) Q1 2020 Earnings Call Transcript
Centogene N.V. (CNTG) Q1 2020 earnings call dated June 15, 2020 Corporate Participants: Sun Kim -- Chief Strategy & Investor Relations Officer, Chief Business